Cutting Edge Information, Jan 2011, Pages: 97
PharmaceuticalPortfolioManagement: Selecting Targets, Filling Pipelines and Preparing for Post-Launch Success Prioritize, Support and Protect Assets
- Among life science companies, the drive to
GBI Research, Aug 2011, Pages: 108
India 102
7.1.1 IT Outsourcing to India 102
7.1.2 Cost of Setting Up A Clinical Data Management Setup In India 103
8 Emerging Pharmaceutical Market: India – Appendix 104
8.1 Market Definitions 104
8.2
CBR Pharma Insights, Sep 2009
Lifecycle Management Strategies - Key Tools to Maximize Return on Investment in a Tough Healthcare Environment Pharmaceutical companies continuing to face the challenges of declining R&D productivity
Ashgate Publishing, June 2011, Pages: 298
Management
The Pharmaceutical Project Management Process
Conclusion
2. Linking Pharmaceutical Projects with Business Strategy
Introduction
Defining Strategy
The Strategy Mix
The Role of Incrementalism
Digital Vector, Oct 2005, Pages: 320
Strategy
Revenue Break-Up
KEY INDIAN FIRMS IN THE INDIAN PHARMACEUTICAL INDUSTRY
- Ranbaxy
Introduction
Business Model
Products And Services
Company Strategy
Revenue Break-Up
- Nicholas Piramal India
GBI Research, Oct 2010, Pages: 120
.
Key Account Management will be Implemented in all Large and Medium Sized Pharmaceutical Companies
Over the last few years, there has been a paradigm shift in the pharmaceutical industry regarding the
MCD Group LLC, Jan 2011, Pages: 203
prescription pharmaceutical products. Our report covers more than 10 therapeutic categories targeted by specialty pharmaceutical companies, such as CNS disorders, pain management, men and women's health, rare
Spectra Intelligence, Nov 2011, Pages: 66
anyone who needs a comprehensive overview of orphan medicines in Europe, including:
- Strategy managers and directors in large pharmaceutical companies
- Biotechnology companies with niche product
Cutting Edge Information, Jan 2008, Pages: 86
looking for strong allies — in the process filling critical portfolio holes and penetrating exciting new markets.
Pharmaceutical Alliance Management focuses on overcoming post-deal management challenges
John Wiley and Sons Ltd, April 2010, Pages: 331
Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries This book describes the way that pharmaceutical projects and programs are currently managed, and offers
Decision Resources, Inc., April 2011, Pages: 41
similarities between these diverse markets and discusses strategies as well as opportunities for pharmaceutical companies in NIEs.
Questions Answered in this Report:
- There is no one-size-fits-all strategy
Decision Resources, Inc., Feb 2011, Pages: 37
State of the Pharmaceutical Industry 2011 - Industry Remodeling Activities Management rather than technology or money has become the crucial rate-limiting factor in creating future value for
Bioplan Associates Inc., April 2008, Pages: 190
the Institute of Clinical Research special interest group in Project
Management.
Mr. David B. Stein, has worked in Pharmaceutical technologies for over twenty years in a variety of roles. He has
GBI Research, Feb 2010, Pages: 85
and analysis on the key lifecycle management strategies implemented by pharmaceutical companies. This pharmaceutical and healthcare report provides information on the Lifestyle Management Strategies
Digital Vector, April 2007, Pages: 325
AND SERVICES
Merck
INTRODUCTION
PRODUCTS AND SERVICES
COMPANY STRATEGY
REVENUE BREAK-UP
Key Indian Firms in the Indian Pharmaceutical Industry
Ranbaxy
INTRODUCTION
BUSINESS MODEL
PRODUCTS AND
Datamonitor, Dec 2010, Pages: 58
global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits
- Gain insight into Lundbeck's
IMS Health, May 2012, Pages: 141
of the company's portfolio of marketed products, providing insights into licensing, lifecycle management, competition
- Pharmaceutical Product by Therapeutic Areas
- Others categories can include
IMS Health, April 2012, Pages: 168
detailed review of the company's portfolio of marketed products, providing insights into licensing, lifecycle management, competition
- Pharmaceutical Product by Therapeutic Areas
- Others categories can
